Related Experiment Video

Updated: Nov 4, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.1K

EPHA2, a promising therapeutic target for hepatocellular carcinoma

Hao Wang1,2, Wei Qiu1,2

  • 1Department of Surgery, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.

Molecular & Cellular Oncology
|May 24, 2021
PubMed

Insights

Targeting Ephrin Receptor A2 (EPHA2) inhibits hepatocellular carcinoma (HCC) growth by blocking key cancer pathways. This discovery offers a new therapeutic strategy for treating liver cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hepatocellular Carcinoma Research

Background:

  • Identifying oncogenesis drivers is crucial for effective hepatocellular carcinoma (HCC) therapeutics.
  • Understanding signaling pathways involved in HCC initiation and progression is key.

Purpose of the Study:

  • To investigate the role of Ephrin Receptor A2 (EPHA2) in HCC.
  • To determine if targeting EPHA2 can suppress HCC initiation and progression.

Main Methods:

  • Investigated the impact of targeting EPHA2 on HCC.
  • Analyzed the dual inhibition of Protein Kinase B (AKT) and Signal Transducer and Activator of Transcription 3 (STAT3) signaling pathways.

Main Results:

  • Targeting EPHA2 was shown to suppress HCC initiation.
  • EPHA2 inhibition effectively halts HCC progression.
  • Dual inhibition of AKT and STAT3 signaling pathways was observed.

Conclusions:

  • Ephrin Receptor A2 (EPHA2) is a critical driver of hepatocellular carcinoma (HCC).
  • Targeting EPHA2 presents a promising therapeutic strategy for HCC by modulating AKT and STAT3 signaling.
Keywords:
AKTEPHA2HCCJAK1STAT3

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.6K
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

2.2K

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
266
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.0K